Mediators of Inflammation / 2015 / Article / Tab 3

Research Article

Expression of Chemokine Receptors on Peripheral Blood T Cells in Children with Chronic Kidney Disease

Table 3

Percentage values of T cell subpopulations, including populations with expression of receptors for selected chemokines in examined children and healthy controls.

Lymphocyte subpopulations %]HD groupCKD groupControl group

T lymphocytes 71,0 (53,4–90,1)69,9 (49,8–89,9)69,3 (36,7–91,9)0,2903
CD4+ T cells41,8 (15,2–55,5)36,6 (20–54,8)34,2 (11,4–58,0)0,3171
CD8+ T cells31,2 (13,5–45,0)30,7 (15,5–45,4)22,2 (8,4–42,1)0,0001
CCR7+ T cells15,4 (2,1–33,7)18,1 (5,3–30,1)2,4 (0,3–49,6)0,0052
CD45RO+CCR7+2,4 (0,4–10,1)3,1 (0,6–21,2)0,9 (0,3–21,2)0,3274
CD28+CCR7+ T cells15,1 (2,1–32,4)16,5 (4,9–29,5)2,6 (0,3–48,5)0,0412
CXCR4+ T cells10,6 (1,3–45,9)23,1 (4,4–45,5)14,4 (2,9–60,1)0,1030
CXCR4+CD4+ T cells2,6 (0,001–31,7)6,5 (0,3–24,3)5,5 (0,0004–38,7)0,4996
CXCR4+CD8+ T cells6,7 (1,3–21,3)15,0 (3,1–29,1)7,0 (1,1–32,0)0,0233
CXCR4+CCR5+ T cells0,8 (0,001–8,5)2,5 (0,6–17,9)2,5 (0,0002–26,0)0,0795
CCR5+ T cells13,0 (3,6–26,9)15,1 (5,1–30,3)12,8 (2,2–53,0)0,4015
CCR5+CD4+ T cells3,2 (1,3–5,6)3,4 (1,4–5,6)3,4 (0,6–9,5)0,6438
CCR5+CD8+ T cells7,4 (1,7–21,7)9,3 (2,6–18,7)5,8 (1,1–41,3)0,9799
CCR4+ T cells5,0 (0,3–22,3)6,0 (0,8–33,6)7,5 (1,0–31,6)0,6464
CCR4+CD4+ T cells4,4 (0,9–47,3)4,5 (1,7–12,3)5,7 (0–15,9)0,2978
CCR4+CD8+ T cells2,0 (0,002–14,2)1,1 (0,001–34,3)0,9 (0,0002–24,7)0,7969
CXCR3+ T cells31,8 (14,8–42,7)30,6 (18,7–43,3)23,4 (11,3–48,8)0,9798
CXCR3+CD4+ T cells10,7 (4,9–18,1)10,0 (4,5–19,3)9,3 (1,7–17,0)0,5450
CXCR3+CD8+ T cells14,4 (8,5–33,2)17,1 (8,9–26,7)16,5 (7,2–27,8)0,8588
CXCR3+CCR5+ T cells10,6 (3,1–23,4)11,8 (4,1–26,6)6,9 (1,3–26,9)0,2822
CXCR3+CXCR4+ T cells7,4 (0,7–20,3)14,3 (2,1–26,9)5,9 (1,0–15,9)0,1994

Percentage values are shown as median value (minimum–maximum).
: significance in ANOVA test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.